Nanexa AB
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D (NCT06439056) | Nanexa AB | 2024-05-27 |
| To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects (NCT05643248) | Nanexa AB | 2022-11-28 |
| Pharmacokinetics, Tolerability and Safety of NEX-18a (NCT05048498) | Nanexa AB | 2021-04-27 |
Track Nanexa AB automatically
Every clearance here is in the API, with alerts when new ones post.